Trouble reading this e-mail? View it in your browser.

9 May 2014
Header image
Highlight of the week


EFPIA Launches Manifesto for an Integrated Life Sciences Strategy for Europe
05 May 2014

(Brussels – 5 May): EFPIA, the European Federation of Pharmaceutical Industries and Associations, is pleased to announce today the launch of its Manifesto for an Integrated [...] Read more



Joint Industry statement on EU-Japan FTA negotiations
06 May 2014

European business organisations, signatories of this statement, are strong proponents of fostering the trade partnership and cooperation between the EU and Japan. We wish to [...] Read more


BIOVISION speakers will debate economic and business challenges in the life sciences market
06 May 2014

Top industry players, European Commission representatives, the WHO, the Innovative Medicine Initiative, the European Institute of Innovation and Technology and Chinese delegations will participate.  BIOVISION’s ninth [...] Read more


EFPIA Welcomes Council Adoption of IMI2 Regulation as a Step Towards a More Innovative EU
06 May 2014

(Brussels – 6 May): EFPIA welcomes the adoption of the IMI2 regulation by the European Council, another step towards the launch of the second Innovative Medicines [...] Read more

From our blog

From our blog

Aiming for a #HealthyEU – Countdown to European Elections – 3 weeks to go : Supporting Sustainable Healthcare Systems
30 April 2014 by Richard Bergström

EFPIA’s Director General, Richard Bergström, continues the #HealthyEU blog series by examining the state of access to medicines in the Ukraine, following a recent visit [...] Read more

From our blog

Aiming for a #HealthyEU – Countdown to European Elections – 2 weeks to go
07 May 2014 by Liam English

Continuing EFPIA’s #HealthyEU campaign, EFPIA’s appointed Communications Director, Liam English, highlights a new tool to help citizens connect with the Health Technology Assessment (HTA) process, [...] Read more

Events calendar

Events Calendar

Webinar: "Breakthrough designation & Medicine adaptive pathways to patients - What does it all mean?
On 12/05/2014

The EMA's announcement of a pilot project in adaptive pathways, the UK government's Early Access to Medicines Scheme (EAMS) and the FDA’s highly-publicised Breakthrough programme [...] Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail